Zogenix (ZGNX) Receives Paragraph IV Notification on Zohydro ER ANDA
Tweet Send to a Friend
On August 13, 2014, Zogenix (Nasdaq: ZGNX) received a paragraph IV certification from Actavis Laboratories FL, Inc. (“Actavis”) advising Zogenix ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
